PL380766A1 - Benzo[d]izooksazol-3- olowe inhibitory DAAO - Google Patents
Benzo[d]izooksazol-3- olowe inhibitory DAAOInfo
- Publication number
- PL380766A1 PL380766A1 PL380766A PL38076604A PL380766A1 PL 380766 A1 PL380766 A1 PL 380766A1 PL 380766 A PL380766 A PL 380766A PL 38076604 A PL38076604 A PL 38076604A PL 380766 A1 PL380766 A1 PL 380766A1
- Authority
- PL
- Poland
- Prior art keywords
- benzisoxazole
- daao inhibitors
- daao
- inhibitors
- Prior art date
Links
- KTZQTRPPVKQPFO-UHFFFAOYSA-N 1,2-benzoxazole Chemical compound C1=CC=C2C=NOC2=C1 KTZQTRPPVKQPFO-UHFFFAOYSA-N 0.000 title 1
- 102100026908 D-amino-acid oxidase Human genes 0.000 title 1
- 108010003989 D-amino-acid oxidase Proteins 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/20—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings condensed with carbocyclic rings or ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US53297803P | 2003-12-29 | 2003-12-29 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL380766A1 true PL380766A1 (pl) | 2007-03-19 |
Family
ID=34748836
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL380766A PL380766A1 (pl) | 2003-12-29 | 2004-12-28 | Benzo[d]izooksazol-3- olowe inhibitory DAAO |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US7166725B2 (https=) |
| EP (1) | EP1711478A2 (https=) |
| JP (1) | JP2007534657A (https=) |
| KR (1) | KR20060128978A (https=) |
| CN (3) | CN102010382A (https=) |
| AU (1) | AU2004312511A1 (https=) |
| BR (1) | BRPI0417910A (https=) |
| CA (1) | CA2552098A1 (https=) |
| CZ (1) | CZ2006426A3 (https=) |
| IL (1) | IL176607A0 (https=) |
| NZ (1) | NZ548213A (https=) |
| PL (1) | PL380766A1 (https=) |
| RU (1) | RU2384574C2 (https=) |
| WO (1) | WO2005066143A2 (https=) |
| ZA (1) | ZA200605384B (https=) |
Families Citing this family (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2007517056A (ja) * | 2003-12-29 | 2007-06-28 | セプラコア インコーポレーテッド | ピロール及びピラゾールｄａａｏ阻害剤 |
| CA2472806A1 (en) | 2004-05-18 | 2005-11-18 | Petro-Canada | Compositions and methods for treating turf insect pests and diseases such as fungal infestations |
| EP2455075B1 (en) | 2005-07-06 | 2018-06-20 | Sunovion Pharmaceuticals Inc. | Process for Preparation of trans 4-(3,4-Dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthalenamine |
| NZ569608A (en) | 2006-01-06 | 2011-09-30 | Sepracor Inc | Tetralone-based monoamine reuptake inhibitors |
| US20070203111A1 (en) | 2006-01-06 | 2007-08-30 | Sepracor Inc. | Cycloalkylamines as monoamine reuptake inhibitors |
| BRPI0707989A2 (pt) | 2006-02-21 | 2011-05-17 | Toyama Chemical Co Ltd | métodos para preparar um derivado de ácido fenilpropiÈnico, um derivado de benzofenona, um derivado de 6-metil-1, 2-benzisoxazol-3(2h) -ona e ácido 2-oxo-2h-cromeno carboxìlico, derivado de 6-(halometil) -1, 2-benzisoxazol-3(2h) -ona, e, derivado de benzofenona ou um sal do mesmo |
| CN101421228B (zh) | 2006-03-31 | 2014-05-21 | 塞普拉柯公司 | 手性酰胺和胺的制备 |
| US7579370B2 (en) * | 2006-06-30 | 2009-08-25 | Sepracor Inc. | Fused heterocycles |
| US7884124B2 (en) * | 2006-06-30 | 2011-02-08 | Sepracor Inc. | Fluoro-substituted inhibitors of D-amino acid oxidase |
| US20080082066A1 (en) * | 2006-10-02 | 2008-04-03 | Weyerhaeuser Co. | Crosslinked carboxyalkyl cellulose fibers having non-permanent and temporary crosslinks |
| US9357768B2 (en) | 2006-10-05 | 2016-06-07 | Suncor Energy Inc. | Herbicidal composition with increased herbicidal efficacy |
| CA2676432A1 (en) | 2007-01-18 | 2008-07-24 | Sepracor, Inc. | Inhibitors of d-amino acid oxidase |
| US7902252B2 (en) * | 2007-01-18 | 2011-03-08 | Sepracor, Inc. | Inhibitors of D-amino acid oxidase |
| CA2688493C (en) | 2007-05-31 | 2016-04-19 | Sepracor Inc. | Phenyl substituted cycloalkylamines as monoamine reuptake inhibitors |
| JP5596678B2 (ja) | 2008-06-26 | 2014-09-24 | サンコー エナジー インコーポレーテッド | 顔料を含む改善された芝草用殺菌製剤 |
| US20100120740A1 (en) * | 2008-08-07 | 2010-05-13 | Sepracor Inc. | Prodrugs of fused heterocyclic inhibitors of d-amino acid oxidase |
| CN102292094B (zh) | 2009-01-20 | 2013-08-14 | 洛杉矶生物医学研究所在哈伯-加州大学洛杉矶分校医疗中心 | 增强神经药方疗效的山梨酸与苯甲酸及其衍生物 |
| US20110034434A1 (en) * | 2009-08-07 | 2011-02-10 | Sepracor Inc. | Prodrugs of fused heterocyclic inhibitors of d-amino acid oxidase |
| CN103338642A (zh) | 2010-09-09 | 2013-10-02 | 桑科能源股份有限公司 | 协同作用的石蜡油和啶酰菌胺杀真菌剂 |
| WO2013181738A1 (en) | 2012-06-04 | 2013-12-12 | Suncor Energy Inc. | Formulations containing paraffinic oil and anti-settling agent |
| US9505753B2 (en) | 2012-08-08 | 2016-11-29 | The Johns Hopkins University | Inhibitors of D-amino acid oxidase |
| US9265458B2 (en) | 2012-12-04 | 2016-02-23 | Sync-Think, Inc. | Application of smooth pursuit cognitive testing paradigms to clinical drug development |
| US9380976B2 (en) | 2013-03-11 | 2016-07-05 | Sync-Think, Inc. | Optical neuroinformatics |
| CN103435561B (zh) * | 2013-08-19 | 2016-08-10 | 上海交通大学 | 一种新型d-氨基酸氧化酶抑制剂及其制备和应用 |
| KR20160029837A (ko) * | 2014-03-24 | 2016-03-15 | 가오슝 창 궁 메모리얼 하스피털 | 치매 또는 경도 인지 장애의 예방 또는 치료용 조성물의 제조에 사용하는 벤조산염의 용도 |
| CN105801511B (zh) * | 2016-04-22 | 2018-01-02 | 山西大学 | 一种1,2‑苯并异恶唑啉‑3‑酮的制备方法 |
| ES2936094T3 (es) | 2016-06-13 | 2023-03-14 | Syneurx Int Taiwan Corp | Cocristales de benzoato de sodio y usos de los mismos |
| RU2765625C2 (ru) | 2016-06-13 | 2022-02-01 | Сайньюрекс Интернэшнл (Тайвань) Корп. | Сокристаллы бензоата лития и их применения |
| CA2938096C (en) | 2016-08-04 | 2019-02-26 | Suncor Energy Inc. | Stabilized emulsions |
| US11369579B2 (en) | 2016-10-24 | 2022-06-28 | Syneurx International (Taiwan) Corp. | Polymorphic forms of sodium benzoate and uses thereof |
| US10336679B2 (en) | 2016-10-24 | 2019-07-02 | Syneurx International (Taiwan) Corp. | Polymorphic forms of sodium benzoate and uses thereof |
| JP6550426B2 (ja) * | 2017-07-26 | 2019-07-24 | カオシュン・チャン・グン・メモリアル・ホスピタル | 認知症または軽度認知障害を予防または治療する組成物を製造するための安息香酸塩の使用 |
| WO2019043635A1 (en) | 2017-09-01 | 2019-03-07 | Richter Gedeon Nyrt. | COMPOUNDS INHIBITING THE ACTIVITY OF D-AMINO ACID OXIDASE |
| US10336724B2 (en) * | 2017-10-18 | 2019-07-02 | Syneurx International (Taiwan) Corp. | D-amino acid oxidase inhibitors and therapeutic uses thereof |
| US10098861B1 (en) | 2017-10-24 | 2018-10-16 | Syneurx International (Taiwan) Corp. | Pharmaceutical composition comprising sodium benzoate compound and clozapine, and uses thereof |
| BR112021014592A2 (pt) | 2019-01-25 | 2021-10-05 | Suncor Energy Inc. | Compostos fotosensibilizadores, métodos de fabricação e aplicação em plantas |
| AU2020222515B2 (en) | 2019-02-15 | 2025-10-09 | Nutrien Ag Solutions (Canada) Inc. | The use of protoporphyrin IX derivatives to improve the health of plants |
| CN117362246B (zh) * | 2023-12-04 | 2024-03-12 | 烟台海川化学制品有限公司 | 一种3-苯基-1,4,2-二恶唑-5-酮的制备方法 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS58177915A (ja) * | 1982-04-12 | 1983-10-18 | Green Cross Corp:The | 抗血栓剤 |
| US4738709A (en) | 1985-01-10 | 1988-04-19 | Ppg Industries, Inc. | Herbicidally active substituted benzisoxazoles |
| JPH0477476A (ja) | 1990-07-19 | 1992-03-11 | Sankyo Co Ltd | 抗潰瘍剤 |
| AU674358B2 (en) | 1992-10-28 | 1996-12-19 | Toyama Chemical Co. Ltd. | Novel 1,2-benzoisoxazole derivative or its salt and brain -protecting agent comprising the same |
| HU221138B1 (en) | 1994-08-30 | 2002-08-28 | Sankyo Co | Condensed isoxazolyloxy- and -thioalkylamine derivatives, process for the preparation thereof and pharmaceutical compositions containing them |
| US5484763A (en) | 1995-02-10 | 1996-01-16 | American Cyanamid Company | Substituted benzisoxazole and benzisothiazole herbicidal agents |
| US5620997A (en) | 1995-05-31 | 1997-04-15 | Warner-Lambert Company | Isothiazolones |
| DE19960917A1 (de) * | 1999-12-17 | 2001-06-21 | Bayer Ag | Neue 3-Oxo-2,1-benzisoxazol-1(3H)-carboxamide zur Behandlung von ZNS-Erkrankungen |
| JP2001247462A (ja) | 2000-03-07 | 2001-09-11 | Otsuka Pharmaceut Co Ltd | ウレアーゼ阻害剤 |
| US20070197610A1 (en) | 2004-03-16 | 2007-08-23 | Janssen Pharmaceutica N.V. | Benzisoxazoles |
-
2004
- 2004-12-28 CN CN2010105590539A patent/CN102010382A/zh active Pending
- 2004-12-28 AU AU2004312511A patent/AU2004312511A1/en not_active Abandoned
- 2004-12-28 ZA ZA200605384A patent/ZA200605384B/en unknown
- 2004-12-28 RU RU2006127436/04A patent/RU2384574C2/ru not_active IP Right Cessation
- 2004-12-28 PL PL380766A patent/PL380766A1/pl not_active Application Discontinuation
- 2004-12-28 CA CA002552098A patent/CA2552098A1/en not_active Abandoned
- 2004-12-28 CN CN2004800422050A patent/CN1922157B/zh not_active Expired - Fee Related
- 2004-12-28 EP EP04815603A patent/EP1711478A2/en not_active Withdrawn
- 2004-12-28 WO PCT/US2004/043547 patent/WO2005066143A2/en not_active Ceased
- 2004-12-28 CN CN201010150424A patent/CN101798291A/zh active Pending
- 2004-12-28 CZ CZ20060426A patent/CZ2006426A3/cs unknown
- 2004-12-28 US US11/024,151 patent/US7166725B2/en not_active Expired - Lifetime
- 2004-12-28 KR KR1020067015383A patent/KR20060128978A/ko not_active Ceased
- 2004-12-28 BR BRPI0417910-2A patent/BRPI0417910A/pt not_active Application Discontinuation
- 2004-12-28 NZ NZ548213A patent/NZ548213A/en unknown
- 2004-12-28 JP JP2006547443A patent/JP2007534657A/ja active Pending
-
2006
- 2006-06-28 IL IL176607A patent/IL176607A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IL176607A0 (en) | 2006-10-31 |
| CN1922157B (zh) | 2011-01-12 |
| CN1922157A (zh) | 2007-02-28 |
| US7166725B2 (en) | 2007-01-23 |
| US20050143434A1 (en) | 2005-06-30 |
| ZA200605384B (en) | 2007-10-31 |
| CA2552098A1 (en) | 2005-07-21 |
| NZ548213A (en) | 2010-05-28 |
| JP2007534657A (ja) | 2007-11-29 |
| RU2384574C2 (ru) | 2010-03-20 |
| RU2006127436A (ru) | 2008-02-10 |
| KR20060128978A (ko) | 2006-12-14 |
| AU2004312511A1 (en) | 2005-07-21 |
| CN102010382A (zh) | 2011-04-13 |
| EP1711478A2 (en) | 2006-10-18 |
| BRPI0417910A (pt) | 2007-04-10 |
| CN101798291A (zh) | 2010-08-11 |
| CZ2006426A3 (cs) | 2006-10-11 |
| WO2005066143A2 (en) | 2005-07-21 |
| WO2005066143A3 (en) | 2005-10-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL380766A1 (pl) | Benzo[d]izooksazol-3- olowe inhibitory DAAO | |
| EG25482A (en) | Inhibitors | |
| IL200842A0 (en) | Pyrrole daao inhibitors | |
| IL160213A0 (en) | Alkyne-aryl phosphodiesterase-4 inhibitors | |
| EP1551801A4 (en) | NOVEL GAMMA-LACTAMES AS INHIBITORS OF BETA-SECRETASE | |
| IL173356A0 (en) | Improved ratchetable open-ended wrench | |
| GB0329667D0 (en) | Core 2 GlcNAc-T inhibitor | |
| EP1532133A4 (en) | NF-: B INHIBITORS | |
| IL175220A0 (en) | Novel 17?? hydroxysteroid dehydrogenase type i inhibitors | |
| AU2003230392A8 (en) | Beta-secretase inhibitors | |
| ZA200505418B (en) | Cathepsin S inhibitors | |
| IL164898A0 (en) | Heterotricyclyl 6-alkylidene-penems as beta-lactamase inhibitors | |
| EP1622615A4 (en) | INHIBITORS OF THE INTEGRASE OF NAPHTHYRIDINE | |
| AP2004003190A0 (en) | Broaspectrum substituted benzisoxazole sulfonamideHIV protease inhibitors. | |
| GB0202187D0 (en) | "Inhibitors" | |
| GB0311195D0 (en) | Glyoxalase inhibitors | |
| AU2003242559A8 (en) | Alkylaminosiloxanes as corrosion inhibitors | |
| AU2003232362A8 (en) | 4-pyrazol-phenylalanine derivatives as ace-nep inhibitors | |
| PL376540A1 (pl) | Pochodne diazepanów stosowane jako inhibitory LFA | |
| GB0312619D0 (en) | Complement inhibitors | |
| GB0300607D0 (en) | Inhibitors | |
| GB0329869D0 (en) | Inhibitors | |
| GB0208094D0 (en) | Inhibitors | |
| GB0217330D0 (en) | Inhibitors | |
| GB0207491D0 (en) | Inhibitors |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| REFS | Decisions on refusal to grant patents (taken after the publication of the particulars of the applications) |